Healthcare provider profile · identity verified

Adrian Ieraci, DO

Family Practice · NORTH LIMA, OH · NPI 1376522326

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	875	282
Levothyroxine Sodium	Levothyroxine Sodium	786	230
Amlodipine Besylate	Amlodipine Besylate	653	201
Lisinopril	Lisinopril	536	147
Metoprolol Succinate	Metoprolol Succinate	392	125
Gabapentin	Gabapentin	383	104
Pantoprazole Sodium	Pantoprazole Sodium	364	96
Rosuvastatin Calcium	Rosuvastatin Calcium	334	120
Escitalopram Oxalate	Escitalopram Oxalate	316	78
Simvastatin	Simvastatin	281	72
Eliquis	Apixaban	264	73
Metformin Hcl	Metformin Hcl	259	77
Omeprazole	Omeprazole	248	81
Losartan Potassium	Losartan Potassium	238	75
Prednisone	Prednisone	218	121
Metoprolol Tartrate	Metoprolol Tartrate	196	53
Furosemide	Furosemide	195	66
Glimepiride	Glimepiride	187	51
Synthroid	Levothyroxine Sodium	175	49
Allopurinol	Allopurinol	171	56
Methylprednisolone	Methylprednisolone	168	140
Tamsulosin Hcl	Tamsulosin Hcl	157	47
Azithromycin	Azithromycin	146	111
Fluticasone Propionate	Fluticasone Propionate	146	65
Albuterol Sulfate Hfa	Albuterol Sulfate	136	56
Citalopram Hbr	Citalopram Hydrobromide	127	33
Xarelto	Rivaroxaban	116	20
Valsartan	Valsartan	114	32
Bupropion Xl	Bupropion Hcl	113	26
Famotidine	Famotidine	109	32
Alendronate Sodium	Alendronate Sodium	107	30
Alprazolam	Alprazolam	104	32
Clonazepam	Clonazepam	103	20
Carvedilol	Carvedilol	100	29
Montelukast Sodium	Montelukast Sodium	98	31
Buspirone Hcl	Buspirone Hcl	97	25
Lorazepam	Lorazepam	96	36
Doxycycline Hyclate	Doxycycline Hyclate	90	67
Levofloxacin	Levofloxacin	90	68
Ozempic	Semaglutide	90	18
Ezetimibe	Ezetimibe	88	33
Hydrochlorothiazide	Hydrochlorothiazide	88	31
Sertraline Hcl	Sertraline Hcl	87	26
Clopidogrel	Clopidogrel Bisulfate	83	32
Potassium Chloride	Potassium Chloride	83	27
Cefdinir	Cefdinir	82	64
Pravastatin Sodium	Pravastatin Sodium	81	24
Tizanidine Hcl	Tizanidine Hcl	81	51
Trazodone Hcl	Trazodone Hcl	81	22
Oxybutynin Chloride Er	Oxybutynin Chloride	79	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	20
Amoxicillin	Amoxicillin	77	64
Metformin Hcl Er	Metformin Hcl	77	25
Pregabalin	Pregabalin	77	18
Venlafaxine Hcl Er	Venlafaxine Hcl	76	17
Doxazosin Mesylate	Doxazosin Mesylate	75	19
Tradjenta	Linagliptin	75	24
Zolpidem Tartrate	Zolpidem Tartrate	75	16
Meloxicam	Meloxicam	66	26
Duloxetine Hcl	Duloxetine Hcl	65	21
Celecoxib	Celecoxib	63	19
Januvia	Sitagliptin Phosphate	62	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	21
Fenofibrate	Fenofibrate	59	19
Hydralazine Hcl	Hydralazine Hcl	59	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	18
Bumetanide	Bumetanide	56	13
Tramadol Hcl	Tramadol Hcl	53	17
Baclofen	Baclofen	52	15
Meclizine Hcl	Meclizine Hcl	52	32
Fluoxetine Hcl	Fluoxetine Hcl	51	11
Atenolol	Atenolol	50	15
Linzess	Linaclotide	50	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	50	17
Trulicity	Dulaglutide	48	11
Mirtazapine	Mirtazapine	45	11
Mupirocin	Mupirocin	45	24
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	44	13
Ropinirole Hcl	Ropinirole Hcl	44	16
Temazepam	Temazepam	44	suppressed
Diclofenac Sodium	Diclofenac Sodium	42	13
Lovastatin	Lovastatin	42	12
Spironolactone	Spironolactone	42	14
Dicyclomine Hcl	Dicyclomine Hcl	40	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	30
Mounjaro	Tirzepatide	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	39	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	39	32
Donepezil Hcl	Donepezil Hcl	38	11
Jardiance	Empagliflozin	38	18
Fenofibrate	Fenofibrate Nanocrystallized	36	12
Triamcinolone Acetonide	Triamcinolone Acetonide	36	25
Raloxifene Hcl	Raloxifene Hcl	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Repatha Syringe	Evolocumab	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Glipizide	Glipizide	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Irbesartan	Irbesartan	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Finasteride	Finasteride	28	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	28	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Tresiba Flextouch U-200	Insulin Degludec	27	suppressed
Ramipril	Ramipril	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Ondansetron Odt	Ondansetron	25	19
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Fluconazole	Fluconazole	24	12
Klor-Con M20	Potassium Chloride	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Repatha Sureclick	Evolocumab	24	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Diazepam	Diazepam	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Cephalexin	Cephalexin	20	17
Fenofibrate	Fenofibrate,micronized	20	suppressed
Naproxen	Naproxen	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Memantine Hcl Er	Memantine Hcl	18	suppressed
Torsemide	Torsemide	18	suppressed
Vascepa	Icosapent Ethyl	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Clindamycin Hcl	Clindamycin Hcl	16	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	12
Azelastine Hcl	Azelastine Hcl	15	suppressed
Digoxin	Digoxin	15	suppressed
Fosinopril Sodium	Fosinopril Sodium	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Nystatin	Nystatin	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Cefuroxime	Cefuroxime Axetil	14	12
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Etodolac	Etodolac	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Diovan	Valsartan	12	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Estradiol	Estradiol	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Tobramycin	Tobramycin	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error